Oncology care in Israel
Hospitals, clinics and medical centers in Israel offering CAR-T-cell-Treatment.
Key planning information for car-t-cell-treatment in Israel.
CAR-T-cell-Treatment in Israel is priced per case at 2 hospitals. Each hospital quotes its own price for your case.
CAR-T-cell-Treatment is listed by 2 hospitals in Israel. The order reshuffles every hour so each gets equal exposure.
Public Hospital
JCIPrice on requestThe largest medical center in Israel and the Middle East, internationally renowned for it's medical excellence. Around 31,000 inpatients are treated annually.
Public University HospitalThe Oncology Institute serves a broad population of cancer patients from central Israel and throughout the country. The fast-track appointment service enables patients to be seen for their initial visit within 48 hours of contacting the institute.
CAR-T cell therapy has shown promising results in treating various types of cancer, including leukemia and lymphoma. However, it is a highly specialized and complex treatment that requires specialized facilities and highly trained medical professionals. For this reason, many patients choose to travel abroad to receive CAR-T cell therapy.
Several countries around the world offer CAR-T cell therapy, including the United States, Europe, China, and Australia. In the United States, the Food and Drug Administration (FDA) has approved two CAR-T cell therapies for the treatment of certain types of leukemia and lymphoma.
What is CAR-T-cell Treatment?CAR-T-cell (chimeric antigen receptor T-cell) therapy is a type of cancer treatment that harnesses the power of the immune system to fight cancer. In this treatment, immune cells are extracted from a patient's body and genetically modified in a lab to recognize and attack cancer cells. The modified cells are then infused back into the patient's bloodstream, where they seek out and destroy cancer cells.
Sub-procedures/types of TreatmentThere are currently two FDA-approved CAR-T-cell therapies: Kymriah and Yescarta. Both are used to treat certain types of blood cancer, including leukemia and lymphoma. However,CAR-T-cell therapy is a relatively new and rapidly evolving field, and clinical trials are ongoing to explore its potential for treating other types of cancer.
Other Points of InterestCAR-T-cell therapy is a complex and specialized treatment that is not widely available. Patients seeking this treatment may need to travel abroad to find a facility that offersit. Additionally, the cost of CAR-T-cell therapy can be prohibitively high,with prices ranging from $373,000 to $475,000 per treatment in the US.
In Europe, CAR-T cell
therapy is also available, with several countries offering this treatment,
including Germany, France, and the United Kingdom. The cost of CAR-T cell
therapy in Europe can vary depending on the country and the specific treatment
being offered. In general, the cost is lower than in the US, with estimates
ranging from €300,000 to €400,000.
China has also emerged as a major player in the field of CAR-T cell therapy, with several hospitals and medical centers offering this treatment. The cost of CAR-T cell therapy in China is generally lower than in the US and Europe, with estimates ranging from $70,000 to $150,000.
Australia has also
recently approved CAR-T cell therapy for the treatment of certain types of
leukemia and lymphoma. However, as with the other countries, the cost of CAR-T
cell therapy in Australia can be high, with estimates ranging from AUD$500,000
to AUD$750,000.
Key facts to plan your treatment: how long it takes, your hospital stay, anaesthesia, risks and recovery.
Common questions
Have a question? Get a free consultation.
Choose a hospital and send your enquiry to its international patient team. Each replies with its own price and plan.
Free consultation • No obligation
ISO